Charles Greg Guyer
CIK 1811096 · View on SEC EDGAR ↗
First SEC filing: Feb. 13, 2026 · Latest: Feb. 13, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 6, 2025 | BMRN | S | 7,034 | $71.28 | $501,384 | 87,655 Direct | -7.43% | Disposed | -4.0% (price as of 2026-08-19) |
| Nov. 12, 2024 | BMRN | S | 5,278 | $66.37 | $350,301 | 68,909 Direct | -7.11% | Disposed | 3.1% (price as of 2026-08-19) |
| Aug. 9, 2023 | BMRN | S | 5,360 | $93.30 | $500,088 | 40,041 Direct | -11.81% | Disposed | -26.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 17, 2025 | BMRN | Stock Option (Right to Buy Common Stock) | Common Stock (30,880) | $71.55 | March 16, 2035 | 30,880 | Acquired |
| March 15, 2024 | BMRN | Stock Option (Right to Buy Common Stock) | Common Stock (23,630) | $83.87 | March 14, 2034 | 23,630 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BMRN
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $600,000 | $500,000 | — | — | $558,000 | — | $93,064 | $5,427,248 |
| 2020 | $392,308 | $250,000 | — | — | $262,500 | — | $162,583 | $6,343,499 |
| 2019 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.